National and Kapodistrian University of Athens
Μελέτη του ρόλου των φυσικών αντιμικροβιακών πεπτιδίων στην παθογένεση των λοιμώξεων σε κιρρωτικούς ασθενείς
Abstract
dc:descriptionObjective: To investigate the expression of natural antimicrobial peptides in chronic liver disease and the presence or not of a correlation with the etiology of liver disease. Moreover, to elucidate the correlation with factors related to bacterial translocation and the possible role of antimicrobial peptides (AMPs) in the pathogenesis of infections in cirrhotic patients and/or the role of AMPs as a biomarker of bacterial translocation in patients with end stage liver disease. Patients and Methods: The concentrations of hBD-1 and sCD14 in plasma and sera of patients with liver cirrhosis, chronic viral hepatitis and healthy controls, and in hepatic veins of cirrhotic patients, were measured by ELISA. The relative mRNA expression of various natural antimicrobial peptides was determined by Real-time RT-PCR in biopsies from the terminal ileum and colon. Moreover, experiments concerning immunohistochemistry and blood and tissue cultures were performed. Results: hBD-1 and sCD14 were significantly upregulated in peripheral blood of cirrhotic patients (18.26 ng/ml, 16.65-21.94, median, 95%CI for hBD-1 and 2777 ng/ml, 2701-3133, median, 95%CI for sCD14) compared to healthy controls (8.85 ng/ml, 7.46-9.69, median, 95%CI, P<0.0001 for hBD-1 and 1671 ng/ml, 1574-2026, median, 95%CI, P<0.0001 for sCD14) and concerning hBD-1 to patients with chronic viral hepatitis too (8.87 ng/ml, 9.09-12.88, median, 95%CI, P<0.0001).. The etiology of cirrhosis did not affect the concentration of either protein. The levels of hBD-1 protein correlated significantly with the levels of sCD14 in blood collected from hepatic veins of cirrhotic patients (Spearman r=0.6, P=0.0045). In contrast, no significant differences were observed in the intestinal mucosal mRNA expression of the Paneth cell specific defensin A5 or hBD-1 between patients with cirrhosis and healthy controls. Conclusions: hBD-1 is upregulated in patients with cirrhosis and highly correlates with LPS-induced protein, sCD14. The correlation of hBD-1 with the presence of gram negative bacteremia indicates a possible role of hBD-1 as a biomarker of bacterial translocation in patients with cirrhosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kaltsa, Garyfallia
- Καλτσά, Γαρυφαλλιά
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36337